China Resources Medical Holdings Company Limited (1PH) — Tangible Net Worth Ratio
China Resources Medical Holdings Company Limited (1PH) has a Tangible Net Worth Ratio of 99.9% as of June 2025. This metric is calculated by deducting intangible assets (€7.13 Million) from net assets (€7.77 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of China Resources Medical Holdings Company for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
China Resources Medical Holdings Company Limited Tangible Net Worth Ratio (2016–2024)
This chart shows how China Resources Medical Holdings Company Limited's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 99.9%, reflecting net assets of €7.77 Billion with intangible assets of €7.13 Million EUR. Also explore how fast is China Resources Medical Holdings Company growing its equity to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for China Resources Medical Holdings Company Limited (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for China Resources Medical Holdings Company Limited from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 1PH market cap.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.9% | €7.50 Billion | €7.78 Million | €13.32 Billion | ▲ +0.5 pp |
| 2023 | 99.4% | €7.01 Billion | €45.30 Million | €13.65 Billion | ▲ +0.3 pp |
| 2022 | 99.0% | €7.00 Billion | €68.66 Million | €11.10 Billion | ▲ +0.1 pp |
| 2021 | 98.9% | €6.85 Billion | €75.35 Million | €10.47 Billion | ▲ +20.1 pp |
| 2020 | 78.8% | €6.34 Billion | €1.35 Billion | €8.96 Billion | ▲ +11.9 pp |
| 2019 | 66.8% | €6.14 Billion | €2.04 Billion | €7.87 Billion | ▲ +3.5 pp |
| 2018 | 63.3% | €5.71 Billion | €2.10 Billion | €7.32 Billion | ▲ +1.0 pp |
| 2017 | 62.3% | €5.60 Billion | €2.11 Billion | €6.91 Billion | ▲ +2.1 pp |
| 2016 | 60.2% | €5.36 Billion | €2.13 Billion | €6.45 Billion | — |